Citius Pharmaceuticals (CTXR) Stock Chart & Stock Price History → Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (From InvestorPlace) (Ad) Free CTXR Stock Alerts $0.65 -0.02 (-2.99%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Citius Pharmaceuticals Stock Price Performance5 Day Performance-6.75%1 Month Performance-19.50%3 Month Performance-18.45%6 Month Performance-16.11%Year-To-Date Performance-14.29%1 Year Performance-42.62% Receive CTXR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. CTXR Stock Chart for Sunday, May, 19, 2024 CTXR Chart by TradingView Citius Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$0.67$0.65-2.86%$0.67$0.64898,575 shs$117.15 million05/16/2024$0.62$0.67+6.85%$0.67$0.62989,497 shs$106.20 million05/15/2024$0.69$0.62-9.15%$0.68$0.602.44 million shs$99.39 million05/14/2024$0.70$0.69-1.11%$0.69$0.67984,077 shs$110.62 million05/13/2024$0.69$0.70+0.09%$0.70$0.67582,729 shs$110.62 million05/10/2024$0.70$0.69-0.91%$0.71$0.661.72 million shs$110.52 million Get the Latest News and Ratings for CTXR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$0.66$0.70+5.70%$0.73$0.651.24 million shs$111.54 million05/08/2024$0.68$0.66-3.10%$0.70$0.641.68 million shs$105.53 million05/07/2024$0.70$0.68-1.89%$0.70$0.661.31 million shs$108.90 million05/06/2024$0.71$0.70-1.04%$0.74$0.671.43 million shs$111.00 million05/03/2024$0.71$0.71-0.28%$0.73$0.69671,135 shs$112.17 million05/02/2024$0.73$0.71-2.66%$0.75$0.681.54 million shs$112.48 million05/01/2024$0.75$0.73-2.68%$0.74$0.72537,567 shs$115.55 million04/30/2024$0.69$0.75+7.85%$0.77$0.70983,029 shs$118.74 million04/29/2024$0.66$0.69+4.09%$0.70$0.66839,630 shs$110.09 million04/26/2024$0.73$0.66-9.25%$0.69$0.642.77 million shs$105.77 million04/25/2024$0.72$0.73+2.25%$0.74$0.68581,041 shs$116.55 million04/24/2024$0.77$0.72-6.62%$0.77$0.70877,841 shs$114.00 million04/23/2024$0.73$0.77+4.51%$0.80$0.73673,359 shs$122.08 million04/22/2024$0.75$0.73-2.68%$0.75$0.701.31 million shs$116.81 million04/19/2024$0.81$0.75-6.34%$0.82$0.721.68 million shs$120.03 million04/18/2024$0.82$0.81-1.31%$1.04$0.776.37 million shs$128.16 million04/17/2024$0.75$0.82+8.86%$0.84$0.75686,430 shs$129.86 million04/16/2024$0.77$0.75-2.01%$0.76$0.73482,635 shs$119.29 million04/15/2024$0.79$0.77-2.87%$0.79$0.75724,923 shs$121.74 million04/12/2024$0.83$0.79-5.45%$0.83$0.78625,548 shs$125.34 million04/11/2024$0.85$0.83-2.00%$0.89$0.70876,345 shs$132.56 million04/10/2024$0.89$0.85-4.50%$0.88$0.83828,642 shs$135.27 million04/09/2024$0.96$0.89-7.36%$0.97$0.86888,899 shs$141.65 million04/08/2024$1.00$0.96-3.84%$1.00$0.95513,187 shs$152.90 million04/05/2024$0.95$1.00+5.40%$1.02$0.90921,431 shs$159.01 million04/04/2024$0.96$0.95-1.73%$0.99$0.921.48 million shs$150.86 million04/03/2024$0.98$0.96-1.20%$1.01$0.96964,613 shs$153.52 million04/02/2024$1.03$0.98-5.18%$1.07$0.931.72 million shs$155.38 million04/01/2024$0.90$1.03+14.79%$1.07$0.911.79 million shs$163.87 million03/29/2024$0.90$0.90$0.93$0.811.28 million shs$142.76 million03/28/2024$0.82$0.90+8.88%$0.93$0.811.28 million shs$142.76 million03/27/2024$0.80$0.82+2.82%$0.83$0.78460,219 shs$131.11 million03/26/2024$0.80$0.80-0.06%$0.82$0.78565,107 shs$127.52 million03/25/2024$0.79$0.80+1.75%$0.84$0.78803,417 shs$127.60 millionget a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024.03/22/2024$0.75$0.79+5.05%$0.79$0.72705,553 shs$125.40 million03/21/2024$0.78$0.75-3.32%$0.78$0.74570,644 shs$119.37 million03/20/2024$0.74$0.78+4.47%$0.78$0.73470,272 shs$123.48 million03/19/2024$0.72$0.74+3.15%$0.75$0.72425,294 shs$118.20 million03/18/2024$0.74$0.72-2.20%$0.80$0.701.09 million shs$114.58 million03/15/2024$0.69$0.74+6.91%$0.74$0.681.61 million shs$117.16 million03/14/2024$0.72$0.69-4.37%$0.73$0.68544,542 shs$109.59 million03/13/2024$0.69$0.72+3.74%$0.73$0.71380,803 shs$114.60 million03/12/2024$0.72$0.69-3.57%$0.74$0.65871,763 shs$110.46 million03/11/2024$0.75$0.72-3.56%$0.75$0.72305,741 shs$114.55 million03/08/2024$0.75$0.75+0.08%$0.78$0.73432,065 shs$118.78 million03/07/2024$0.72$0.75+4.34%$0.75$0.72308,561 shs$118.69 million03/06/2024$0.73$0.72-2.20%$0.77$0.70516,591 shs$113.76 million03/05/2024$0.77$0.73-4.53%$0.78$0.73577,924 shs$116.32 million03/04/2024$0.78$0.77-1.49%$0.80$0.76314,533 shs$121.84 million03/01/2024$0.77$0.78+1.18%$0.80$0.76319,259 shs$123.68 million02/29/2024$0.79$0.77-2.23%$0.82$0.76438,332 shs$122.24 million02/28/2024$0.75$0.79+4.30%$0.80$0.75428,961 shs$125.02 million02/27/2024$0.74$0.75+1.67%$0.76$0.74413,658 shs$119.87 million02/26/2024$0.76$0.74-2.50%$0.80$0.74540,829 shs$117.89 million02/23/2024$0.79$0.76-3.80%$0.79$0.76414,174 shs$120.92 million02/22/2024$0.77$0.79+2.61%$0.80$0.76396,104 shs$125.69 million02/21/2024$0.75$0.77+2.65%$0.78$0.74388,901 shs$122.49 million02/20/2024$0.80$0.75-5.67%$0.78$0.73868,520 shs$119.33 million02/19/2024$0.80$0.80$0.86$0.771.22 million shs$126.50 million Related Companies: CRVS Stock Chart PMVP Stock Chart RLMD Stock Chart ACET Stock Chart CYTT Stock Chart CLRB Stock Chart CNTB Stock Chart RZLT Stock Chart ABEO Stock Chart IMUX Stock Chart Receive CTXR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTXR) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.